Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,265.00
Bid: 2,250.00
Ask: 2,280.00
Change: 25.00 (1.12%)
Spread: 30.00 (1.333%)
Open: 2,250.00
High: 2,265.00
Low: 2,230.00
Prev. Close: 2,240.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant Contract Win

31 Oct 2017 07:00

RNS Number : 0253V
Craneware plc
31 October 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

31 October 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the renewal and significant expansion of an existing contract with a growing hospital operator in the US.

 

This $6m win sees the extension of a relationship that has been in place since 2007, with the renewal of the customer's existing Value Cycle solutions and the roll out of these same solutions to further facilities that have been recently acquired by this hospital network. The contract is expected to deliver $3.5m of incremental revenue over this new five year term as the hospital network rolls out these solutions at its additional facilities.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.

 

Keith Neilson, CEO of Craneware plc, commented, "The expansion of this relationship demonstrates the strategic importance of Craneware's Value Cycle solutions to our customers, as they extend their own hospital networks throughout the US. The strength of our solutions and the value they deliver to all customers, including large and complex health systems, allows us to deepen our relationship with our customers as they address the challenges resulting from the continued evolution to the new value based re-imbursement environment.

 

"Having enjoyed our positive working relationship for a decade, we now look forward to continuing to deliver sustainable value throughout this new term."

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGMMFGLGLGNZM
Date   Source Headline
9th Nov 20188:55 amRNSDividend Currency Election
7th Nov 201810:42 amRNSResult of AGM
6th Nov 20187:00 amRNSAGM Statement and Capital Markets Day
16th Oct 20187:00 amRNSBlock listing Interim Review
11th Oct 201810:50 amRNSPosting of Annual Report and Notice of AGM
5th Oct 20184:39 pmRNSTotal Voting Rights
5th Oct 20182:55 pmRNSHolding(s) in Company
18th Sep 20182:06 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
11th Sep 201811:10 amRNSHolding(s) in Company
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
7th Sep 201811:40 amRNSHolding(s) in Company
5th Sep 201812:20 pmRNSGrant of Options & Long Term Incentive Plan Awards
4th Sep 20187:00 amRNSFinal Results
1st Aug 20187:00 amRNSAppointment of Joint Broker
10th Jul 20187:00 amRNSTrading Update and Significant Contract Win
17th Apr 20181:55 pmRNSBlock listing Interim Review
12th Apr 20189:54 amRNSHolding(s) in Company
6th Apr 20183:10 pmRNSDividend Currency Election
27th Mar 20181:52 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
14th Mar 20182:11 pmRNSAdditional Listing - Blocklisting of Securities
8th Mar 20187:00 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSHalf-year Report
16th Feb 201811:53 amRNSHolding(s) in Company
13th Feb 20187:00 amRNSSignificant Contract Wins
31st Jan 20182:59 pmRNSTotal Voting Rights
26th Jan 20182:49 pmRNSHolding(s) in Company
26th Jan 201812:10 pmRNSTotal Voting Rights and Director/PDMR Shareholding
23rd Jan 201812:05 pmRNSResult of Share Buyback
17th Jan 20185:59 pmRNSGrant of Options & Long Term Incentive Plan Awards
16th Jan 20187:00 amRNSShare Buyback
8th Jan 20187:00 amRNSTrading Update and Significant Contract Win
29th Nov 20177:00 amRNSHolding(s) in Company
10th Nov 20171:43 pmRNSDividend Currency Election
8th Nov 20175:00 pmRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement
31st Oct 20177:00 amRNSSignificant Contract Win
27th Oct 20172:07 pmRNSHolding(s) in Company
18th Oct 20172:06 pmRNSBlock listing Interim Review
12th Oct 201712:15 pmRNSPosting of Annual Report and Notice of AGM
22nd Sep 201712:06 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSFinal Results
11th Jul 20177:00 amRNSTrading Update
5th Apr 20177:00 amRNSHolding(s) in Company
31st Mar 20175:04 pmRNSDividend Currency Election
27th Mar 20176:26 pmRNSGrant of Options & Long Term Incentive Plan Award
23rd Mar 20177:00 amRNSSignificant Contract Win
7th Mar 20177:00 amRNSHalf-year Report
31st Jan 20177:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.